Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

AFPaCC

The Australian Familial Pancreatic Cancer Cohort is designed to explore the inherited aspects of pancreatic cancer

Australian Familial Pancreatic Cancer Cohort

The Australian Familial Pancreatic Cancer Cohort (AFPaCC) is a registry for individuals or families who have multiple relatives affected by pancreatic cancer. It is estimated that 5-10% of all pancreatic cancers are hereditary. AFPaCC investigates genetic and environmental factors that may account for the clustering of pancreatic cancer in some Australian families.

Read More…

Request to join AFPaCC

If you have a family history of pancreatic cancer, you may be eligible to join the Australian Familial Pancreatic Cancer Cohort (AFPaCC). Contact the clinical coordinator using the form below, to find out how you can be a part of this important research.

Read More…

Pancreatic Cancer Screening Trial

The first Australian pancreatic cancer screening trial has commenced at St Vincent's Hospital, Sydney and is now recruiting at Austin Health, Melbourne. The aim of the study is to assess the use of endoscopic ultrasound (EUS) as a screening modality in a population considered to be at a high risk of developing pancreatic cancer.

Read More…